Biogen Idec Inc (BIIB) & TESARO Inc (TSRO): Top Biotech Stocks from Robyn Karnauskas Of Deutsche Bank

In the back drop of the biotech S&P ETF impacted by the S&P shedding market valuation by close to 7 % this week, Robyn Karnauskas who heads Deutsche Bank’s biotechnology vertical as its director spoke to CNBC and provided tips to investors on the likely biotech performers in the small cap and big cap categories in the immediate future.

Under the large cap category, Karnauskas mentioned the Cambridge headquartered Biogen Idec Inc (NASDAQ:BIIB) as a likely outperformer. She summarized that the impending launch of its much awaited haemophilia drug will drive up valuations in this drug maker’s stock. She went on to estimate that the price target on the stock of this $75 billion market capped firm would jump up in the $30 to $100 region per share, from its current valuations over the next two quarters, primarily driven by the underlying lower valuation of the stock.

Biogen Idec Inc (NASDAQ:BIIB)

Therefore, Karnauskas recommended the stock to investors by explaining that she foresaw “only upside on this stock.”  and no downside in the numbers. She further went on to underscore that the valuation jump “expectations are very low. Since the proof of concept for the biology here”

Under the small cap category, Karnauskas picked TESARO Inc (NASDAQ:TSRO), with a market cap of $1.14 billion. She listed out three key reasons as to why she thinks investors should buy into the stock at these levels.

The first point of attraction in the stock of TESARO Inc (NASDAQ:TSRO) for Karnauskas was the fact that the company is  expected to release a drug by the beginning of next year, on the back of strong clinical trial data.

The second point of import that Karnauskas pointed out was the fact that the company has a second drug candidate for ovarian cancer, which is also looking very promising and expects this to be launched next year.

She went on to predict that this drug has the potential to earn the company in the region of $200 million to $3 billion. She further highlighted the fact that TESARO Inc (NASDAQ:TSRO) has a exceptional management team, which has prior experience in growing drug firms and selling them at huge marked up pricing.  She also pointed that TESARO has a big chance to be a takeover target in the future.

Disclosure: none

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 9 Most Dangerous Countries for Tourists to Visit

Reign of Terror: The 10 Most Ruthless Politicians in History

On the Move: The 10 Fastest Growing Businesses in 2015

Fast Money: The 10 Highest Paying Fast Food Restaurants

Mixing It Up: The 14 Best Music Mashups of 2014

Rito Pls Buff: The 10 Least Played Champions in LoL Season 4

10 Covers of Popular Songs that are Better than the Originals

Must See TV: The 9 Most Anticipated Shows of 2015

The 15 Biggest Box Office Bombs of All Time

10 Things The World Can’t Stand About Americans

Picture Perfect: The 6 Smartphones with the Best Cameras

The 10 Best Countries To Work In the World

A Profitable Day At The Track: 5 Tips For Betting On Horses

Tearing You Apart: 6 Bad Habits That Ruin Relationships

Learning on the Job: The 6 Biggest Mistakes Parents Make

Shopaholics Rejoice: The 12 Biggest Malls in the World

Fright Night: 10 Horror Movies Based on True Stories

Mach Mania: The 10 Fastest Jets in the World

Military Heavyweights: The 10 Countries with the Most Tanks

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!